Background: The EQ-5D-5L is a generic preference-based questionnaire developed by the
EuroQol Group to measure health-related quality of life (HRQoL) in 2005. Since its …

Introduction Randomised studies have demonstrated efficacy of disease-modifying
therapies in relapsing remitting multiple sclerosis (RRMS). However it is unclear how the …

Aim. To explore the efficacy of home‐based, computerised, cognitive rehabilitation in
patients with multiple sclerosis using neuropsychological assessment and advanced …

Background: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
disease characterized by unpredictable attacks of the optic nerves and spinal cord that …

Objective The reliability and validity of generic utility measures have not yet been
summarized in people with multiple sclerosis (MS). It is important to assess the psychometric …

Introduction Myasthenia gravis (MG) is a neuromuscular disease causing extreme muscular
fatigue, triggering problems with vision, swallowing, speech, mobility, dexterity, and …

Background: There is limited information regarding the safety, feasibility and acceptability of
behaviour-change interventions to increase physical activity (PA) and reduce sedentary …

abstract Objectives To estimate health state utility values (HSUVs) for multiple sclerosis (MS)
by key demographic and clinical characteristics. Methods Data from a UK prospective …

Multiple Sclerosis requires long-term disease management, but tracking patients through the
use of clinical surveys is hindered by high costs and patient burden. In this work, we …

More than 700,000 people suffer from multiple sclerosis (MS) in Europe. This implies that
more than 1 million people are affected by this disease through their role as caregivers and …